🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kevin Roehle

Novartis (Switzerland)

ORCID: 0000-0003-4944-5767

Also affiliated with Harvard University, Novartis (China), Dana-Farber Cancer Institute, Novartis (United States)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer.

23 citations

Kevin Roehle, Nataly Manjarrez‐Orduño, Stephanie K. Dougan, Courtney T. Stump

13 citations

Kevin Roehle, Elisa Bello, M. Aladdin Bhuiyan, Tamara Biary, Stephanie J. Crowley +15 more